• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迈向精准的心血管代谢预防:来自基于全国人群的 ORISCAV-LUX 2 研究中机器学习、半监督聚类方法的结果。

Towards precision cardiometabolic prevention: results from a machine learning, semi-supervised clustering approach in the nationwide population-based ORISCAV-LUX 2 study.

机构信息

Deep Digital Phenotyping Research Unit, Department of Population Health, Luxembourg Institute of Health, 1A-B, rue Thomas Edison, 1445, Strassen, Luxembourg.

Center of Epidemiology and Population Health UMR 1018, Inserm, Gustave Roussy Institute, Paris South - Paris Saclay University, Villejuif, France.

出版信息

Sci Rep. 2021 Aug 6;11(1):16056. doi: 10.1038/s41598-021-95487-5.

DOI:10.1038/s41598-021-95487-5
PMID:34362963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8346462/
Abstract

Given the rapid increase in the incidence of cardiometabolic conditions, there is an urgent need for better approaches to prevent as many cases as possible and move from a one-size-fits-all approach to a precision cardiometabolic prevention strategy in the general population. We used data from ORISCAV-LUX 2, a nationwide, cross-sectional, population-based study. On the 1356 participants, we used a machine learning semi-supervised cluster method guided by body mass index (BMI) and glycated hemoglobin (HbA1c), and a set of 29 cardiometabolic variables, to identify subgroups of interest for cardiometabolic health. Cluster stability was assessed with the Jaccard similarity index. We have observed 4 clusters with a very high stability (ranging between 92 and 100%). Based on distinctive features that deviate from the overall population distribution, we have labeled Cluster 1 (N = 729, 53.76%) as "Healthy", Cluster 2 (N = 508, 37.46%) as "Family history-Overweight-High Cholesterol ", Cluster 3 (N = 91, 6.71%) as "Severe Obesity-Prediabetes-Inflammation" and Cluster 4 (N = 28, 2.06%) as "Diabetes-Hypertension-Poor CV Health". Our work provides an in-depth characterization and thus, a better understanding of cardiometabolic health in the general population. Our data suggest that such a clustering approach could now be used to define more targeted and tailored strategies for the prevention of cardiometabolic diseases at a population level. This study provides a first step towards precision cardiometabolic prevention and should be externally validated in other contexts.

摘要

鉴于心血管代谢疾病发病率的迅速增加,我们迫切需要更好的方法来预防尽可能多的病例,并从针对所有人的一刀切方法转变为针对普通人群的精准心血管代谢预防策略。我们使用了来自 ORISCAV-LUX 2 的数据,这是一项全国性的、横断面的、基于人群的研究。在 1356 名参与者中,我们使用了一种由体重指数 (BMI) 和糖化血红蛋白 (HbA1c) 指导的机器学习半监督聚类方法,以及一组 29 个心血管代谢变量,来确定对心血管代谢健康感兴趣的亚组。使用 Jaccard 相似指数评估聚类稳定性。我们观察到 4 个具有非常高稳定性的聚类(范围在 92%到 100%之间)。基于与总体人群分布不同的特征,我们将聚类 1(N=729,53.76%)标记为“健康”,聚类 2(N=508,37.46%)标记为“有家族史的超重高胆固醇”,聚类 3(N=91,6.71%)标记为“严重肥胖前驱糖尿病炎症”,聚类 4(N=28,2.06%)标记为“糖尿病高血压心血管健康不良”。我们的工作提供了对心血管代谢健康的深入描述,从而更好地理解了普通人群的心血管代谢健康。我们的数据表明,这种聚类方法现在可以用于在人群层面定义更有针对性和定制化的心血管代谢疾病预防策略。本研究为精准心血管代谢预防迈出了第一步,应在其他环境中进行外部验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9716/8346462/c6928be72045/41598_2021_95487_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9716/8346462/24ee96d24865/41598_2021_95487_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9716/8346462/c10289d079dd/41598_2021_95487_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9716/8346462/c6928be72045/41598_2021_95487_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9716/8346462/24ee96d24865/41598_2021_95487_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9716/8346462/c10289d079dd/41598_2021_95487_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9716/8346462/c6928be72045/41598_2021_95487_Fig3_HTML.jpg

相似文献

1
Towards precision cardiometabolic prevention: results from a machine learning, semi-supervised clustering approach in the nationwide population-based ORISCAV-LUX 2 study.迈向精准的心血管代谢预防:来自基于全国人群的 ORISCAV-LUX 2 研究中机器学习、半监督聚类方法的结果。
Sci Rep. 2021 Aug 6;11(1):16056. doi: 10.1038/s41598-021-95487-5.
2
Application of Machine Learning to Identify Clustering of Cardiometabolic Risk Factors in U.S. Adults.机器学习在美国成年人中心血管代谢风险因素聚类识别中的应用。
Diabetes Technol Ther. 2019 May;21(5):245-253. doi: 10.1089/dia.2018.0390. Epub 2019 Apr 10.
3
Challenges and benefits of integrating diverse sampling strategies in the observation of cardiovascular risk factors (ORISCAV-LUX 2) study.整合不同抽样策略在心血管风险因素观察(ORISCAV-LUX 2)研究中的挑战和益处。
BMC Med Res Methodol. 2019 Feb 4;19(1):27. doi: 10.1186/s12874-019-0669-0.
4
Acculturation, immigration status and cardiovascular risk factors among Portuguese immigrants to Luxembourg: findings from ORISCAV-LUX study.文化适应、移民身份与卢森堡葡萄牙裔移民的心血管风险因素:ORISCAV-LUX 研究结果。
BMC Public Health. 2012 Oct 11;12:864. doi: 10.1186/1471-2458-12-864.
5
Geographic Variations in Cardiometabolic Risk Factors in Luxembourg.卢森堡心血管代谢危险因素的地理差异。
Int J Environ Res Public Health. 2017 Jun 16;14(6):648. doi: 10.3390/ijerph14060648.
6
Self-reported body weight and height: an assessment tool for identifying children with overweight/obesity status and cardiometabolic risk factors clustering.自报的体重和身高:一种用于识别超重/肥胖状态和心血管代谢危险因素聚集的儿童评估工具。
Matern Child Health J. 2013 Feb;17(2):282-91. doi: 10.1007/s10995-012-0972-4.
7
Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: the Bogalusa Heart Study.腰高比在评估正常体重和超重/肥胖儿童中心性肥胖状态及相关心血管代谢风险特征中的应用:博加卢萨心脏研究。
BMC Pediatr. 2010 Oct 11;10:73. doi: 10.1186/1471-2431-10-73.
8
First nationwide survey on cardiovascular risk factors in Grand-Duchy of Luxembourg (ORISCAV-LUX).卢森堡大公国(ORISCAV-LUX)心血管危险因素首次全国性调查。
BMC Public Health. 2010 Aug 10;10:468. doi: 10.1186/1471-2458-10-468.
9
Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S.心血管代谢危险因素簇对美国健康相关生活质量的影响
Obesity (Silver Spring). 2007 Feb;15(2):511-21. doi: 10.1038/oby.2007.580.
10
Association between cardiometabolic risk factors and body mass index, waist circumferences and body fat in a Zanzibari cross-sectional study.桑给巴尔一项横断面研究中,心血管代谢危险因素与体重指数、腰围及体脂之间的关联
BMJ Open. 2019 Jul 4;9(7):e025397. doi: 10.1136/bmjopen-2018-025397.

引用本文的文献

1
Predicting incident cardio-metabolic disease among persons with and without depressive and anxiety disorders: a machine learning approach.预测患有和未患有抑郁及焦虑症的人群中心血管代谢疾病的发病情况:一种机器学习方法。
Soc Psychiatry Psychiatr Epidemiol. 2025 Feb 18. doi: 10.1007/s00127-025-02857-9.
2
Genetic Evidence for Distinct Biological Mechanisms That Link Adiposity to Type 2 Diabetes: Toward Precision Medicine.遗传证据表明肥胖与 2 型糖尿病之间存在不同的生物学机制联系:迈向精准医学。
Diabetes. 2024 Jun 1;73(6):1012-1025. doi: 10.2337/db23-1005.
3
Metabolic basis of cardiac dysfunction in cancer patients.

本文引用的文献

1
Partha Kar: Our approach to tackling obesity needs rethinking.帕尔塔·卡尔:我们应对肥胖问题的方法需要重新思考。
BMJ. 2020 Aug 6;370:m3034. doi: 10.1136/bmj.m3034.
2
Effectiveness of the Ready to Reduce Risk (3R) complex intervention for the primary prevention of cardiovascular disease: a pragmatic randomised controlled trial.《Ready to Reduce Risk(3R)综合干预方案在心血管疾病一级预防中的有效性:一项实用随机对照试验》
BMC Med. 2020 Jul 27;18(1):198. doi: 10.1186/s12916-020-01664-0.
3
Bariatric Surgery and Long-term Survival in Patients With Obesity and End-stage Kidney Disease.
癌症患者心脏功能障碍的代谢基础。
Curr Opin Cardiol. 2024 May 1;39(3):138-147. doi: 10.1097/HCO.0000000000001118. Epub 2024 Feb 21.
4
New insights in the mechanisms of weight-loss maintenance: Summary from a Pennington symposium.体重维持机制的新见解:彭宁顿研讨会综述。
Obesity (Silver Spring). 2023 Dec;31(12):2895-2908. doi: 10.1002/oby.23905. Epub 2023 Oct 16.
5
Phenotyping the obesities: reality or utopia?肥胖表型化:现实还是乌托邦?
Rev Endocr Metab Disord. 2023 Oct;24(5):767-773. doi: 10.1007/s11154-023-09829-x. Epub 2023 Aug 4.
6
Precision medicine in complex diseases-Molecular subgrouping for improved prediction and treatment stratification.复杂疾病的精准医学-分子亚群分组以改善预测和治疗分层。
J Intern Med. 2023 Oct;294(4):378-396. doi: 10.1111/joim.13640. Epub 2023 Apr 24.
7
Recent Advancements in Emerging Technologies for Healthcare Management Systems: A Survey.医疗管理系统新兴技术的最新进展:一项调查
Healthcare (Basel). 2022 Oct 3;10(10):1940. doi: 10.3390/healthcare10101940.
8
Analysing breast cancer survivors' acceptance profiles for using an electronic pillbox connected to a smartphone application using Seintinelles, a French community-based research tool.使用法国基于社区的研究工具Seintinelles,分析乳腺癌幸存者对使用连接到智能手机应用程序的电子药盒的接受情况。
Front Pharmacol. 2022 Sep 27;13:889695. doi: 10.3389/fphar.2022.889695. eCollection 2022.
肥胖症合并终末期肾病患者的减重手术与长期生存。
JAMA Surg. 2020 Jul 1;155(7):581-588. doi: 10.1001/jamasurg.2020.0829.
4
Obtaining evidence base for the development of Feel4Diabetes intervention to prevent type 2 diabetes - a narrative literature review.为开发 Feel4Diabetes 干预措施以预防 2 型糖尿病获取证据基础 - 叙述性文献回顾。
BMC Endocr Disord. 2020 Mar 12;20(Suppl 1):140. doi: 10.1186/s12902-019-0468-y.
5
Systematic Review of Polygenic Risk Scores for Type 1 and Type 2 Diabetes.1 型和 2 型糖尿病多基因风险评分的系统评价。
Int J Mol Sci. 2020 Mar 2;21(5):1703. doi: 10.3390/ijms21051703.
6
Characterizing the weight-glycemia phenotypes of type 1 diabetes in youth and young adulthood.描述青少年和青年期1型糖尿病的体重-血糖表型。
BMJ Open Diabetes Res Care. 2020 Jan;8(1). doi: 10.1136/bmjdrc-2019-000886.
7
The integrative biology of type 2 diabetes.2 型糖尿病的综合生物学。
Nature. 2019 Dec;576(7785):51-60. doi: 10.1038/s41586-019-1797-8. Epub 2019 Dec 4.
8
Effectiveness of a Brief Self-determination Theory-Based Smoking Cessation Intervention for Smokers at Emergency Departments in Hong Kong: A Randomized Clinical Trial.基于简短自我决定理论的戒烟干预措施对香港急诊科吸烟者的有效性:一项随机临床试验。
JAMA Intern Med. 2020 Feb 1;180(2):206-214. doi: 10.1001/jamainternmed.2019.5176.
9
Challenges and benefits of integrating diverse sampling strategies in the observation of cardiovascular risk factors (ORISCAV-LUX 2) study.整合不同抽样策略在心血管风险因素观察(ORISCAV-LUX 2)研究中的挑战和益处。
BMC Med Res Methodol. 2019 Feb 4;19(1):27. doi: 10.1186/s12874-019-0669-0.
10
A Network Analysis of Biomarkers for Type 2 Diabetes.网络分析用于 2 型糖尿病的生物标志物。
Diabetes. 2019 Feb;68(2):281-290. doi: 10.2337/db18-0892. Epub 2018 Nov 8.